Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimetabolite interactions with epidermal growth factor

E A Kopecky1, D S Rootman

  • 1Department of Ophthalmology, University of Toronto, Toronto Hospital, Ontario.

Current Eye Research
|March 1, 1996
PubMed
Summary

Antimetabolites like 5-fluorouracil (5FU) and mitomycin C (MMC) impact corneal healing. Epidermal growth factor (EGF) did not improve healing delayed by these antimetabolites, suggesting limited therapeutic use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-reported outcomes of autologous serum tears for the treatment of dry eye disease in a large cohort.

The ocular surface·2019
Same author

Half top hat wound configuration for penetrating keratoplasty: 1-year results.

The British journal of ophthalmology·2009
Same author

Fibrin glue versus sutures for attaching the conjunctival autograft in pterygium surgery: a prospective observer masked clinical trial.

The British journal of ophthalmology·2008
Same author

Femtosecond laser versus manual dissection for top hat penetrating keratoplasty.

The British journal of ophthalmology·2008
Same author

Corneal wound malapposition after penetrating keratoplasty: an optical coherence tomography study.

The British journal of ophthalmology·2008
Same author

Half-top-hat--a new wound configuration for penetrating keratoplasty.

The British journal of ophthalmology·2007

Area of Science:

  • Ophthalmology
  • Wound Healing
  • Pharmacology

Background:

  • Antimetabolites, including 5-fluorouracil (5FU) and mitomycin C (MMC), are known to impede wound healing processes.
  • Epidermal growth factor (EGF) has demonstrated efficacy in accelerating corneal epithelial wound healing.

Purpose of the Study:

  • To investigate the impact of Epidermal Growth Factor (EGF) on corneal epithelial wound healing previously affected by antimetabolite treatments.
  • To evaluate the efficacy of EGF in counteracting the delayed wound healing caused by 5FU and MMC.

Main Methods:

  • New Zealand White rabbits received subconjunctival 5FU or topical MMC, alongside saline controls.
  • Anterior stromal wounds were created and perfused with saline or EGF (50 µg/ml) for 6 hours.
  • Wound healing was quantitatively assessed via morphometry over a 6-day period.

Main Results:

  • Topical MMC significantly delayed corneal wound healing compared to controls (P < 0.05); subconjunctival 5FU did not (P > 0.05).
  • MMC significantly delayed healing more than 5FU, irrespective of saline or EGF perfusion.
  • EGF perfusion did not significantly alter corneal wound healing rates in the presence of either 5FU or MMC (P > 0.05).

Conclusions:

  • Subconjunctival 5FU does not affect corneal wound healing, while topical MMC significantly delays it.
  • EGF treatment failed to overcome the inhibitory effects of MMC on corneal wound healing.
  • EGF therapy may not be beneficial for treating complications arising from antimetabolite use in corneal healing.

Related Experiment Videos